pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Preclinical
BA-102
Phelan-McDermid Syndrome (22q13.3 Deletion Syndrome)
$XAIRBeyond Air, Inc.
0 catalysts
Preclinical
BA-3142
Head And Neck Cancer
$BCABBioAtla, Inc.
0 catalysts
BACITRACIN ZINC AND POLYMYXIN B SULFATE
BACITRACIN ZINC AND POLYMYXIN B SULFATE (BACITRACIN ZINC AND POLYMYXIN B SULFATE)
BAUSCH AND LOMB
0 catalysts
Phase 1
BAL-0891
← prev
page 61 of 231
next →
131
Pain89
Neurology1
Adenocarcinoma Of The Gastroesophageal Junction
Sillajen Biotherapeutics
0 catalysts
Preclinical
BAL-200
Anthrax
iNtRON Biotechnology Inc
0 catalysts
BALANCED SALT
BALANCED SALT (SODIUM CHLORIDE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM ACETATE, AND SODIUM CITRATE)
B BRAUN
0 catalysts
Phase 2
BAT-8006
Epithelial Ovarian Cancer
Bio-Thera Solutions Ltd
0 catalysts
Phase 2
BAY-3401016
Alport Syndrome
Bayer AG
0 catalysts
Phase 2
BB-1701
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast…
Bliss Biopharmaceutical (Hangzhou) Co Ltd
0 catalysts
Phase 2
BB-301
Pabparna
Oculopharyngeal Muscular Dystrophy
$BNTCBenitec Biopharma Inc.
0 catalysts
Preclinical
BB-IO
Unspecified Infectious Diseases
BroadenBio Co Ltd
0 catalysts
Phase 1
BBI-940
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
$BOLDBoundless Bio, Inc.
0 catalysts
Phase 1
BBO-11818
Pancreatic Ductal Adenocarcinoma
$BBOTBridgeBio Oncology Therapeutics, Inc.
0 catalysts
Phase 1
BBO-8520
Metastatic Colorectal Cancer
$BBOTBridgeBio Oncology Therapeutics, Inc.
0 catalysts
Phase 2
BBP-812
Canavan Disease
Aspa Therapeutics Inc
0 catalysts
Preclinical
BBS10
MeiraGTx UK II Ltd
0 catalysts
Preclinical
BBT-059
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome)
Bolder Biotechnology Inc
0 catalysts
Phase 2
BBT-207
Non-Small Cell Lung Cancer
Parataxis Korea Inc
0 catalysts
Phase 2
BBT-401
Ulcerative Colitis
Parataxis Korea Inc
0 catalysts
Phase 2
BBT-877
Idiopathic Pulmonary Fibrosis
Parataxis Korea Inc
0 catalysts
Phase 1
BC-3195
Endometrial Cancer
BioCity Biopharma Co Ltd
0 catalysts
Preclinical
BCB-276
Pediatric Diffuse Intrinsic Pontine Glioma
BrainChild Bio Inc
0 catalysts
Phase 2
BCX-17725
Netherton Syndrome (Bamboo Hair)
$BCRXBIOCRYST PHARMACEUTICALS INC
0 catalysts
Preclinical
BCyIF-1
Solid Tumor
BioCytics
0 catalysts
Phase 2
BDTX-4933
Metastatic Colorectal Cancer
Les Laboratoires Servier SAS
0 catalysts
Phase 2
BE-101
Hemophilia B (Factor IX Deficiency)
Be Biopharma Inc
0 catalysts
Preclinical
BEA-17
Glioblastoma Multiforme (GBM)
Beactica Therapeutics AB
0 catalysts
Phase 2
BEAM-201
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
$BEAMBeam Therapeutics Inc.
0 catalysts
Phase 2
BEAM-301
Glycogen Storage Disease 1A
$BEAMBeam Therapeutics Inc.
0 catalysts
Phase 2
BEAM-302
Alpha-1 Antitrypsin Deficiency (A1AD)
$BEAMBeam Therapeutics Inc.
0 catalysts